These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


267 related items for PubMed ID: 11703471

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [The application of migraine disability assessment questionnaire (MIDAS)].
    Hung PH, Fuh JL, Wang SJ.
    Acta Neurol Taiwan; 2006 Mar; 15(1):43-8. PubMed ID: 16599285
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Reliability, validity, and clinical utility of the Migraine-ACT questionnaire.
    Kilminster SG, Dowson AJ, Tepper SJ, Baos V, Baudet F, D'Amico D.
    Headache; 2006 Apr; 46(4):553-62. PubMed ID: 16643548
    [Abstract] [Full Text] [Related]

  • 7. Comparison of Short Form-36 and Migraine Disability Assessment questionnaire in patients with migraine.
    Fuh JL, Wang SJ.
    Clin J Pain; 2006 Apr; 22(6):564-8. PubMed ID: 16788344
    [Abstract] [Full Text] [Related]

  • 8. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R, Schreiber C.
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [Abstract] [Full Text] [Related]

  • 9. Disability pattern in chronic migraine with medication overuse: a comparison with migraine without aura.
    D'Amico D, Grazzi L, Usai S, Rigamonti A, Curone M, Bussone G.
    Headache; 2005 May; 45(5):553-60. PubMed ID: 15953274
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Headache prophylaxis with BoNTA: patient characteristics.
    Silberstein SD, Marmura MJ, Shaw J, Yu S.
    Headache; 2010 Jan; 50(1):63-70. PubMed ID: 19549156
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Assessing the impact of migraine.
    Dowson AJ.
    Curr Med Res Opin; 2001 Jan; 17(4):298-309. PubMed ID: 11922404
    [Abstract] [Full Text] [Related]

  • 14. Identifying patients who require a change in their current acute migraine treatment: the Migraine Assessment of Current Therapy (Migraine-ACT) questionnaire.
    Dowson AJ, Tepper SJ, Baos V, Baudet F, D'Amico D, Kilminster S.
    Curr Med Res Opin; 2004 Jul; 20(7):1125-35. PubMed ID: 15265257
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of early intervention with almotriptan vs placebo on migraine-associated functional disability: results from the AEGIS Trial.
    Freitag F, Smith T, Mathew N, Rupnow M, Greenberg S, Mao L, Finlayson G, Wright P, Biondi D, AEGIS Investigator Study Group.
    Headache; 2008 Mar; 48(3):341-54. PubMed ID: 18302700
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.